Another Down Month for GWDN Index; Clinical Data Drops 24 Percent in June

For the second month in a row, the GWDN Index and the broader market dropped sharply. Only nine firms in the Index saw their stock price gain ground in June.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories